Photo by jmason from unsplash
Esketamine is an N‐methyl‐D‐aspartic acid (NMDA) receptor antagonist, which has stronger sedative and analgesic effects and fewer adverse events than ketamine. The effects of low‐dose esketamine on haemodynamics and postoperative… Click to show full abstract
Esketamine is an N‐methyl‐D‐aspartic acid (NMDA) receptor antagonist, which has stronger sedative and analgesic effects and fewer adverse events than ketamine. The effects of low‐dose esketamine on haemodynamics and postoperative quality of recovery in elderly patients have not been evaluated. To evaluate whether low‐dose esketamine can be safely used for anaesthesia induction in the elderly.
Keywords:
induction elderly;
effects low;
anaesthesia induction;
dose esketamine;
esketamine;
low dose
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!